A retrospective study to evaluate the safety and efficacy of venetoclax in patients with immunoglobulin light chain (AL) amyloidosis
Latest Information Update: 29 Aug 2019
At a glance
- Drugs Venetoclax (Primary) ; Bortezomib; Dexamethasone; Lenalidomide
- Indications Amyloid light-chain amyloidosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 29 Aug 2019 New trial record